As of 2024-12-12, the Relative Valuation of Biovaxys Technology Corp (BIOV.CN) is (0.00) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.06 CAD, the upside of Biovaxys Technology Corp based on Relative Valuation is -101.6%.
The range of the Relative Valuation is (0.00) - (0.00) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.0x - 0.1x | 0.0x |
| Forward P/E multiples | 0.0x - 0.1x | 0.0x |
| Fair Price | (0.00) - (0.00) | (0.00) |
| Upside | -101.3% - -101.9% | -101.6% |
| Date | P/E |
| 2024-12-09 | -2.89 |
| 2024-12-06 | -3.15 |
| 2024-12-05 | -3.41 |
| 2024-12-04 | -3.67 |
| 2024-12-03 | -3.67 |
| 2024-12-02 | -3.67 |
| 2024-11-29 | -3.15 |
| 2024-11-28 | -3.15 |
| 2024-11-27 | -3.15 |
| 2024-11-26 | -3.15 |
| 2024-11-25 | -3.41 |
| 2024-11-22 | -3.41 |
| 2024-11-21 | -3.67 |
| 2024-11-20 | -3.41 |
| 2024-11-19 | -3.41 |
| 2024-11-18 | -3.67 |
| 2024-11-15 | -3.67 |
| 2024-11-14 | -3.67 |
| 2024-11-13 | -3.67 |
| 2024-11-12 | -3.41 |
| 2024-11-11 | -3.67 |
| 2024-11-08 | -3.94 |
| 2024-11-07 | -3.41 |
| 2024-11-06 | -3.94 |
| 2024-11-05 | -3.67 |
| 2024-11-04 | -3.67 |
| 2024-11-01 | -3.41 |
| 2024-10-31 | -3.67 |
| 2024-10-30 | -3.94 |
| 2024-10-29 | -3.94 |
| 2024-10-28 | -3.41 |
| 2024-10-25 | -3.67 |
| 2024-10-24 | -3.67 |
| 2024-10-23 | -3.67 |
| 2024-10-22 | -3.15 |
| 2024-10-21 | -2.89 |
| 2024-10-18 | -2.62 |
| 2024-10-17 | -2.62 |
| 2024-10-16 | -2.36 |
| 2024-10-15 | -2.36 |
| 2024-10-11 | -2.36 |
| 2024-10-10 | -2.62 |
| 2024-10-09 | -2.62 |
| 2024-10-08 | -2.62 |
| 2024-10-07 | -2.36 |
| 2024-10-04 | -2.36 |
| 2024-10-03 | -2.36 |
| 2024-10-02 | -2.36 |
| 2024-10-01 | -2.62 |
| 2024-09-30 | -2.62 |